Analysts
DISCLAIMER - Issued by the Directors and Management of SkyePharma PLC (the "Company")
Research analysts have from time to time published material commenting on the Company. Any opinions, estimates or forecasts regarding the Company's performance made by such analysts are theirs alone and do not represent opinions, forecasts or predictions of the Company or its Management. By distributing the information below, the Company does not imply its endorsement of or concurrence with such information. The Company does not accept any responsibility whatsoever for the views of these or any other analysts.
The following analysts currently issue reports on the Company:
| Edison |
Robin Davison |
020 3077 5737 |
| Piper Jaffray |
Michael Aitkenhead |
020 3142 8704 |
| Singer |
Shawn Manning |
020 3205 7633 |
Piper Jaffray are brokers to the Company.
Investors may wish to contact any of the above analysts directly in order to obtain copies of the reports issued. Unless otherwise noted below, these cannot be obtained directly from SkyePharma and there is no obligation upon the analyst to provide any report. Any reports issued may have become out of date following publication and should be read accordingly.
2010
2009
2008
Copyright 2009, SkyePharma. All Rights Reserved.
SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 105 Piccadilly, London, W1J 7NJ, United Kingdom